Dr Jerel Saito, MD | |
2230 Liliha St, Honolulu, HI 96817 | |
(808) 547-6243 | |
(808) 547-6605 |
Full Name | Dr Jerel Saito |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 30 Years |
Location | 2230 Liliha St, Honolulu, Hawaii |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1245210863 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085B0100X | Radiology - Body Imaging | 9503 (Hawaii) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Sutter Tracy Community Hospital | Tracy, CA | Hospital |
Regional Medical Center Of San Jose | San jose, CA | Hospital |
Santa Clara Valley Medical Center | San jose, CA | Hospital |
San Joaquin General Hospital | French camp, CA | Hospital |
Memorial Hospital Los Banos | Los banos, CA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Bay Imaging Consultants Medical Group Inc | 9537069125 | 132 |
Central Valley Imaging Medical Associates Inc | 8628064953 | 38 |
Central Valley Imaging Medical Associates Inc | 8628064953 | 38 |
County Of San Joaquin | 6002703436 | 119 |
County Of Santa Clara | 1254244973 | 732 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today it has filed an amendment with the U.S. Food and Drug Administration, as well as initiated filing with regulatory agencies in other countries, to amend the statistical design and analysis plan of its pivotal, international Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC).
A study in Australia suggests that reduced lung function in infancy was associated with wheezing beyond childhood at 18 years of age, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it has entered into an agreement to acquire the rights to ifetroban, a new Phase II development product.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the United States Court of Appeals for the Federal Circuit has ruled in favor of Hologic, by reversing the previous decisions reached by the United States District Court for the Northern District of California, in favor of SenoRx, Inc.
The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in tuberculosis."
› Verified 8 days ago
Entity Name | Central Valley Imaging Medical Associates Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1275523169 PECOS PAC ID: 8628064953 Enrollment ID: O20170302001533 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today it has filed an amendment with the U.S. Food and Drug Administration, as well as initiated filing with regulatory agencies in other countries, to amend the statistical design and analysis plan of its pivotal, international Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC).
A study in Australia suggests that reduced lung function in infancy was associated with wheezing beyond childhood at 18 years of age, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it has entered into an agreement to acquire the rights to ifetroban, a new Phase II development product.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the United States Court of Appeals for the Federal Circuit has ruled in favor of Hologic, by reversing the previous decisions reached by the United States District Court for the Northern District of California, in favor of SenoRx, Inc.
The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in tuberculosis."
› Verified 8 days ago
Entity Name | Bay Imaging Consultants Medical Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1134681067 PECOS PAC ID: 9537069125 Enrollment ID: O20190711003334 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today it has filed an amendment with the U.S. Food and Drug Administration, as well as initiated filing with regulatory agencies in other countries, to amend the statistical design and analysis plan of its pivotal, international Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC).
A study in Australia suggests that reduced lung function in infancy was associated with wheezing beyond childhood at 18 years of age, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it has entered into an agreement to acquire the rights to ifetroban, a new Phase II development product.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the United States Court of Appeals for the Federal Circuit has ruled in favor of Hologic, by reversing the previous decisions reached by the United States District Court for the Northern District of California, in favor of SenoRx, Inc.
The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in tuberculosis."
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jerel Saito, MD 941 Kamehameha Hwy, Ste 208, Pearl City, HI 96782-2516 Ph: (808) 454-5200 | Dr Jerel Saito, MD 2230 Liliha St, Honolulu, HI 96817 Ph: (808) 547-6243 |
News Archive
OncoGenex Pharmaceuticals, Inc. announced today it has filed an amendment with the U.S. Food and Drug Administration, as well as initiated filing with regulatory agencies in other countries, to amend the statistical design and analysis plan of its pivotal, international Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of non-small cell lung cancer (NSCLC).
A study in Australia suggests that reduced lung function in infancy was associated with wheezing beyond childhood at 18 years of age, according to a report published Online First by JAMA Pediatrics, a JAMA Network publication.
Cumberland Pharmaceuticals Inc., a specialty pharmaceutical company focused on hospital acute care and gastroenterology markets, today announced that it has entered into an agreement to acquire the rights to ifetroban, a new Phase II development product.
Hologic, Inc., a leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, today announced that the United States Court of Appeals for the Federal Circuit has ruled in favor of Hologic, by reversing the previous decisions reached by the United States District Court for the Northern District of California, in favor of SenoRx, Inc.
The Infectious Disease Research Institute today announced it has received a multi-million dollar grant from the Bill and Melinda Gates Foundation for "Chemical genomics for the identification of targets and leads in tuberculosis."
› Verified 8 days ago
Dr. Samuel M. Wu, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 | |
Dr. Horia Vulpe, MD, CM Radiology Medicare: Accepting Medicare Assignments Practice Location: 1301 Punchbowl St, Honolulu, HI 96813 Phone: 808-691-8777 Fax: 808-691-8780 | |
Howard K. Arimoto, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 347 N Kuakini St, Honolulu, HI 96817 Phone: 808-522-0190 Fax: 808-523-9068 | |
Dr. Mark T. Kanemori, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1650 Liliha St, Suite 105, Honolulu, HI 96817 Phone: 808-524-3131 Fax: 808-524-3189 | |
Dr. Ferdinand K Hui, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 550 S Beretania St Ste 405, Honolulu, HI 96813 Phone: 808-691-8866 | |
Dr. Jean Paul Colon-pons, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1380 Lusitana St Ste 1007, Honolulu, HI 96813 Phone: 808-748-4488 Fax: 808-748-4799 | |
Kristen T. Nagata, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3288 Moanalua Rd, Honolulu, HI 96819 Phone: 808-432-0000 |